MLK is the newest addition to the University of Maryland's Biopark set to bring a wave of innovation and opportunity to ...
"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...
The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related ...
Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...
It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...
A homegrown biotech focused on infectious diseases like Ebola and Zika virus has shuttered a major component of its business.
Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...